"Nanomedicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
| Descriptor ID |
D050997
|
| MeSH Number(s) |
H01.603.600 J01.897.115.625 J01.897.520.600.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nanomedicine".
Below are MeSH descriptors whose meaning is more specific than "Nanomedicine".
This graph shows the total number of publications written about "Nanomedicine" by people in this website by year, and whether "Nanomedicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 2 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 2 | 4 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 1 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nanomedicine" by people in Profiles.
-
Understanding nanoparticle-liver interactions in nanomedicine. Expert Opin Drug Deliv. 2024 Jun; 21(6):829-843.
-
Primary Human Breast Cancer-Associated Endothelial Cells Favor Interactions with Nanomedicines. Adv Mater. 2024 Jul; 36(28):e2403986.
-
Toward the Scalable, Rapid, Reproducible, and Cost-Effective Synthesis of Personalized Nanomedicines at the Point of Care. Nano Lett. 2024 Jan 24; 24(3):920-928.
-
Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer. Drug Deliv Transl Res. 2023 Jun; 13(6):1621-1653.
-
Nanomedicine as a magic bullet for combating lymphoma. J Control Release. 2022 07; 347:211-236.
-
Drug delivery approaches for HuR-targeted therapy for lung cancer. Adv Drug Deliv Rev. 2022 01; 180:114068.
-
Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma. Int J Mol Sci. 2021 Sep 07; 22(18).
-
Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. Adv Drug Deliv Rev. 2021 11; 178:113918.
-
Nanomedicines accessible in the market for clinical interventions. J Control Release. 2021 02 10; 330:372-397.
-
Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 07; 12(4):e1623.